Boosting chemotherapeutic response: Citric acid-coated Mn0.9Zn0.1Fe2O4 nanoparticles mediated magnetic fluid hyperthermia potentiates docetaxel efficacy in LNCaP cells.
Current therapeutic strategies for prostate cancer (PC) are associated with significant adverse effects, drug resistance, and many other limitations. Docetaxel (DTX), a widely used chemotherapeutic agent for PC, requires high doses, often resulting in severe side effects. Combining DTX with hyperthermia has the potenti...